LaSalle St. Investment Advisors’s Pfizer PFE Stock Holding History

LaSalle St. Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Buy	14,076 +826	+6%	+$21.6K	0.04%	299
2026 Q1	$372K	Buy	13,250 +2,731	+26%	+$72.7K	0.05%	256
2025 Q4	$261K	Buy	10,519 +1,037	+11%	+$26.2K	0.04%	301
2025 Q3	$241K	Sell	9,482 -133	-1%	-$3.28K	0.04%	298
2025 Q2	$233K	Buy	+9,615	New	+$224K	0.06%	284
2023 Q4	–	Sell	-6,346	Closed	-$210K	–	136
2023 Q3	$210K	Buy	+6,346	New	+$224K	0.1%	111
2023 Q2	–	Sell	-6,433	Closed	-$262K	–	132
2023 Q1	$262K	Buy	6,433 +2,269	+54%	+$98K	0.12%	103
2022 Q4	$213K	Buy	+4,164	New	+$200K	0.1%	90

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LaSalle St. Investment Advisors's PFE Position: Q2 2026 in Review

LaSalle St. Investment Advisors increased its Pfizer (PFE) stake by 6.2% in Q2 2026, buying an estimated $21.6K and bringing the position to 14,076 shares worth $339K. The position accounts for 0.04% of the portfolio, ranked #299.

LaSalle St. Investment Advisors first reported a position in PFE in Q4 2022 and has held it in 8 quarters since. The position peaked at $372K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

LaSalle St. Investment Advisors held 14,076 shares of Pfizer worth $339K as of Q2 2026.
LaSalle St. Investment Advisors bought 826 Pfizer shares in Q2 2026, an estimated $21.6K.
Pfizer made up 0.04% of LaSalle St. Investment Advisors's portfolio in Q2 2026, its #299 holding.
LaSalle St. Investment Advisors first reported a position in Pfizer in Q4 2022 and has held it in 8 quarters since.
LaSalle St. Investment Advisors's Pfizer position peaked at $372K in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.